Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU.

International journal of oncology

Volumn 19, Issue 2, 2001, Pages 359-365

  Gomez Manzano, C ^a   Lemoine, M G ^a   Hu, M ^a   He, J ^a   Mitlianga, P ^a   Liu, T J ^a   Yung, A W ^a   Fueyo, J ^a   Groves, M D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DACARBAZINE; DNA BINDING PROTEIN; DRUG DERIVATIVE; E2F1 PROTEIN, HUMAN; PROTEIN P16INK4A; TEMOZOLOMIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

ADENOVIRUS; ARTICLE; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; GENE TRANSFER; GENETICS; GLIOMA; HUMAN; IC 50; METABOLISM; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CELL CYCLE PROTEINS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DACARBAZINE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE TRANSFER TECHNIQUES; GLIOMA; HUMANS; INHIBITORY CONCENTRATION 50; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035430176     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.19.2.359     Document Type: Article

References (0)